earnings
PC
NASDAQ · PCSA
Processa Pharmaceuticals, Inc.
Healthcare · Biotechnology
$2.08
Up+$0.23 (+12.43%)
Updated Sep 13, 2026, 6:08 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 15.65M
- P/E ratio
- -1.01
- Dividend yield
- 0.00%
- 52-week range
- $1.67 – $3.45
- Volume
- 39.35K
- Avg. volume
- 9.87M
Price performance
PCSA price history
1M range · 19 trading sessions · Daily adjusted prices
PCSA closed at $2.08 after 19 trading sessions, down 2.35% for the selected period.
- Last close
- $2.08
- Period change
- -2.35%
- Period low
- $1.85
- Period high
- $2.18
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.90 | $2.12 | $1.90 | $2.08 | 39.35K |
| Sep 10, 2026 | $1.99 | $2.03 | $1.82 | $1.85 | 102.28K |
| Sep 9, 2026 | $2.08 | $2.11 | $1.98 | $1.99 | 25.47K |
| Sep 8, 2026 | $2.15 | $2.165 | $2.05 | $2.16 | 35.84K |
| Sep 4, 2026 | $2.02 | $2.0825 | $2.01 | $2.06 | 12.34K |
| Sep 3, 2026 | $2.09 | $2.10 | $2.05 | $2.05 | 10.3K |
| Sep 2, 2026 | $2.05 | $2.18 | $2.05 | $2.10 | 12.72K |
| Sep 1, 2026 | $2.04 | $2.125 | $2.02 | $2.05 | 14.53K |
| Aug 31, 2026 | $2.08 | $2.11 | $2.02 | $2.05 | 15.7K |
| Aug 28, 2026 | $2.08 | $2.14 | $2.02 | $2.06 | 9.59K |
| Aug 27, 2026 | $2.07 | $2.20 | $2.07 | $2.11 | 15.87K |
| Aug 26, 2026 | $2.18 | $2.22 | $2.12 | $2.13 | 21.97K |
| Aug 25, 2026 | $2.17 | $2.28 | $2.15 | $2.18 | 56.22K |
| Aug 24, 2026 | $2.11 | $2.18 | $2.04 | $2.17 | 30.51K |
| Aug 21, 2026 | $2.21 | $2.22 | $2.00 | $2.08 | 75.97K |
| Aug 20, 2026 | $2.14 | $2.1999 | $2.11 | $2.145 | 27.54K |
| Aug 19, 2026 | $2.18 | $2.18 | $2.11 | $2.15 | 25.07K |
| Aug 18, 2026 | $2.13 | $2.1536 | $2.04 | $2.10 | 51.88K |
| Aug 17, 2026 | $2.43 | $2.43 | $2.12 | $2.13 | 61.31K |
Latest PCSA news
The latest Smart Investors Daily articles mentioning PCSA.
Stock researchResearch & News · Competitors
Loading stock research…